Inhibition of dopamine uptake by D2 antagonists: an in vivo study (original) (raw)
Modulation of In Vivo Dopamine Release by D 2 but Not D 1 Receptor Agonists and Antagonists
Tony Altar
Journal of Neurochemistry, 1987
View PDFchevron_right
Altered dopamine release and uptake kinetics in mice lacking D2 receptors
Yvonne Schmitz
The Journal of neuroscience, 2002
View PDFchevron_right
Effects of D-2 Antagonists on Frequency-Dependent Stimulated Dopamine Overflow in Nucleus Accumbens and Caudate-Putamen
leslie may
Journal of Neurochemistry, 1989
View PDFchevron_right
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour
Clas Sonesson
Journal of Neural Transmission, 1994
View PDFchevron_right
D2 dopamine receptor specific brain uptake of 11C labelled YM-09151-2
Kentaro Hatano
Journal of Nuclear Medicine
View PDFchevron_right
Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens
Eric Engleman
European Journal of Pharmacology, 2001
View PDFchevron_right
Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor
Tahira Farooqui
Biochemical Pharmacology, 1988
View PDFchevron_right
The electrophysiology of dopamine (D2) receptors: A study of the actions of dopamine on corticostriatal transmission
G. Arbuthnott
Neuroscience, 1983
View PDFchevron_right
Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study
Julian Millar
British Journal of Pharmacology, 1988
View PDFchevron_right
Inhibition of Dopamine Release Via Presynaptic D2 Receptors: Time Course and Functional Characteristics In Vivo
Francois Gonon
2001
View PDFchevron_right
Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
Robert McQuade
European Journal of Pharmacology, 2011
View PDFchevron_right
N-0437:a selective D-2 dopamine receptor agonist in in vitro and in vivo models
Pieter Tepper
European Journal of Pharmacology, 1988
View PDFchevron_right
D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2
Masatoshi Itoh
Journal of Nuclear Medicine, 1989
View PDFchevron_right
Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists
Julio Cano
European Journal of Pharmacology, 1993
View PDFchevron_right
D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: In vivo voltammetric data revisited
taoufiq fechtali
Journal of Physiology-Paris, 1994
View PDFchevron_right
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors
Tomas de Paulis
Life Sciences, 1991
View PDFchevron_right
Discrepancies in apparent dopamine D2 receptor occupancy between 3 H-raclopride and 3 H-N-methylspiperone
Antony Gee
Journal of Neural Transmission, 1999
View PDFchevron_right
Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study
Judith R Walters
Brain Research, 1987
View PDFchevron_right
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level
Olivier Civelli
Neuroscience Letters, 1990
View PDFchevron_right
Dopamine D 2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D 2 receptor signaling
Shaun Jordan
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2007
View PDFchevron_right
Evaluation of Dopamine D-2 Receptor Occupancy by Clozapine, Risperidone, and Haloperidol In Vivo in the Rodent and Nonhuman Primate Brain Using 18F-Fallypride
Jogeshwar Mukherjee, Bradley Christian
Neuropsychopharmacology, 2001
View PDFchevron_right
The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors
Kjell Fuxe
Neuroscience, 1994
View PDFchevron_right
Activation of dopamine D1 receptors does not affect D2 receptor-mediated inhibition of acetylcholine release in rabbit striatum
Clemens Allgaier
Naunyn-Schmiedeberg's Archives of Pharmacology, 1992
View PDFchevron_right
Functional Fast Scan Cyclic Voltammetry Assay to Characterize Dopamine D2 and D3 Autoreceptors in the Mouse Striatum
francis maina
Acs Chemical Neuroscience, 2010
View PDFchevron_right
Effect of the inhibition of dopamine uptake on the dopamine- and dimethyldopamine-induced-inhibition of the potassium-evoked release of [3H]acetylcholine from striatal slices
Tahira Farooqui
General pharmacology, 1989
View PDFchevron_right
Opposite Influences of Endogenous Dopamine D1 and D2 Receptor Activation on Activity States and Electrophysiological Properties of Striatal Neurons: Studies CombiningIn Vivo Intracellular Recordings and Reverse Microdialysis
Anthony Grace
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
View PDFchevron_right
EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors
Jorn Arnt
European Journal of Pharmacology, 1988
View PDFchevron_right
Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET
Jolanta Opacka-Juffry
Journal of Neural Transmission, 1998
View PDFchevron_right
D 2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes
N. Vivas
British Journal of Pharmacology, 1997
View PDFchevron_right
Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum
Ichiro Kusumi
European Journal of Pharmacology, 1997
View PDFchevron_right
Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release
Hans Fibiger
European Journal of Pharmacology, 1992
View PDFchevron_right
The effects ofl-DOPA on in vitro dopamine release from striatum
Michael Zigmond
View PDFchevron_right
Intrastriatal Dopamine Infusion Reverses Compensatory Increases in D2-Dopamine Receptors in the 6-OHDA Lesioned Rat
Jan Vesper, Siegfried Vogel, Christian Woiciechowsky
Neurodegeneration, 1995
View PDFchevron_right